Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: Medopachak Ghanvati: In Hyperlipidemia Medopachak Ghanvati 500mg will be given orally with Ushnodak Twice a day.
Total duration of treatment-
60days
Followup â??0, 30, 60 days.
Thoro
Sponsors
Dr Seema Vitthal Rathod
Dr Gunvant Yeola
Eligibility
Inclusion criteria
Inclusion criteria: Patients with high blood lipid profile.Lipid profile showing any one or more of the following criteria was considered diagnostic of hyperlipidemia .
Exclusion criteria
Exclusion criteria: 1.Pregnant women & lactating mother. 2.Chronic illness and infection like TB, CA and HIV infection. 3.Patient is suffering with psychological disorders like anxiety, depression. 4.Patient with Respiratory Diseases Complications, Coronary Heart Disease,Infective Hepatitis,Alcoholic Hepatitis or Renal Disease etc. 5.Drug induced Hyperlipidemia. 6.Patients having a history of untreated thyroid disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Changes in Lipid Profile by Medopachak Ghanvati towards the Normal levels at the end treatment. Lipid profile showing increased level anyone or more of following criteria will considered diagnostic of hyperlipidemia: Serum Total Cholesterol Serum Triglycerides Serum HDL Cholesterol Serum LDL Cholesterol Serum VLDL Cholesterol Timepoint: 60days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To reduce risk factors for many diseases including cardiovascular disease and metabolic syndrome 2.TO assess the efficacy of medopachk Ghanvati in HyperlipidemiaTimepoint: 60days | — |
Countries
India
Contacts
Public ContactDR SEEMA VITTHAL RATHOD
DR.D.Y.Patil College Of Ayurved and Research Centre Pimpri Pune
Outcome results
None listed